Acurx board of directors approves bitcoin as treasury reserve asset

Staten island, n.y. , nov. 20, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("we" or "acurx" or the "company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company's board of directors approved the purchase of up to $1 million in bitcoin to hold as a treasury reserve asset.
ACXP Ratings Summary
ACXP Quant Ranking